Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-01-30 Purchase | 2024-03-06 9:52 pm | Allogene Therapeutics Inc. | ALLO | Parker Geoffrey M. CHIEF FINANCIAL OFFICER | 190 | $3.595 | $683 | 819,590 (Direct) | View |
| 2023-07-27 Purchase | 2023-07-31 07:58 am | Better Therapeutics Inc. | BTTX | Parker Geoffrey M. Director | 685,025 | $0.7299 | $500,000 | 1,081,388 (Indirect Direct) | View |
| 2023-06-13 Purchase | 2023-06-14 10:54 am | PERRIGO Co plc | PRGO | Parker Geoffrey M. Director | 10,000 | $33.06 | $330,637 | 47,084 (Indirect Direct) | View |
| 2023-04-10 Purchase | 2023-04-12 4:15 pm | Better Therapeutics Inc. | BTTX | Parker Geoffrey M. Director | 303,030 | $0.825 | $250,000 | 396,363 (Indirect Direct) | View |
| 2023-03-06 Purchase | 2023-03-07 07:48 am | PERRIGO Co plc | PRGO | Parker Geoffrey M. Director | 5,000 | $38.05 | $190,270 | 33,040 (Indirect Direct) | View |
| 2022-06-13 Purchase | 2022-06-14 4:25 pm | Better Therapeutics Inc. | BTTX | Parker Geoffrey M. Director | 25,000 | $1.4473 | $36,183 | 93,333 (Indirect Direct) | View |
| 2022-03-29 Purchase | 2022-03-31 4:38 pm | Better Therapeutics Inc. | BTTX | Parker Geoffrey M. Director | 15,000 | $2.1487 | $32,230 | 68,333 (Indirect Direct) | View |
| 2021-12-16 Purchase | 2021-12-17 12:34 pm | PERRIGO Co plc | PRGO | Parker Geoffrey M. Director | 5,000 | $36.85 | $184,270 | 24,609 (Indirect Direct) | View |
| 2021-12-14 Purchase | 2021-12-16 4:32 pm | Better Therapeutics Inc. | BTTX | Parker Geoffrey M. Director | 20,000 | $4.94 | $98,800 | 53,333 (Indirect) | View |
| 2021-03-17 Purchase | 2021-03-18 2:45 pm | PERRIGO Co plc | PRGO | Parker Geoffrey M. Director | 2,500 | $41.29 | $103,218 | 16,591 (Indirect Direct) | View |
| 2021-03-04 Sale | 2021-03-08 8:28 pm | ChemoCentryx Inc. | CCXI | Parker Geoffrey M. Director | 31,910 | $56.61 | $1,806,448 | 129,603 (Indirect Direct) | View |
| 2020-12-10 Purchase | 2020-12-10 7:46 pm | Tricida Inc. | TCDA | Parker Geoffrey M. CFO and EVP | 15,000 | $6.78 | $101,700 | 250,837 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-10-21 Tax Withholding | 2024-10-23 4:21 pm | N/A N/A | Allogene Therapeutics Inc. | ALLO | Parker Geoffrey M. CHIEF FINANCIAL OFFICER | 36,404 | $2.84 | 1,131,988 (Direct) | View |
| 2024-05-16 Option Award | 2024-05-20 6:02 pm | N/A N/A | Allogene Therapeutics Inc. | ALLO | Parker Geoffrey M. CHIEF FINANCIAL OFFICER | 344,828 | $2.9 | 1,164,418 (Direct) | View |
| 2024-05-15 Exercise | 2024-05-16 7:28 pm | N/A N/A | PERRIGO Co plc | PRGO | Parker Geoffrey M. Director | 8,764 | $0 | 30,166 (Direct) | View |
| 2024-05-15 Tax Withholding | 2024-05-16 7:28 pm | N/A N/A | PERRIGO Co plc | PRGO | Parker Geoffrey M. Director | 4,207 | $30.22 | 30,166 (Direct) | View |
| 2024-05-14 Option Award | 2024-05-16 7:28 pm | N/A N/A | PERRIGO Co plc | PRGO | Parker Geoffrey M. Director | 9,904 | $0 | 30,166 (Direct) | View |
| 2024-05-15 Exercise | 2024-05-16 7:28 pm | N/A N/A | PERRIGO Co plc | PRGO | Parker Geoffrey M. Director | 8,764 | $30.22 | 30,166 (Direct) | View |
| 2024-01-25 Option Award | 2024-01-31 5:47 pm | N/A 2034-01-25 | Allogene Therapeutics Inc. | ALLO | Parker Geoffrey M. CHIEF FINANCIAL OFFICER | 133,339 | $0 | 923,339 (Direct) | View |
| 2023-12-18 Option Award | 2023-12-20 5:22 pm | N/A N/A | Better Therapeutics Inc. | BTTX | Parker Geoffrey M. Director | 3,750 | $0 | 1,085,138 (Direct) | View |
| 2023-10-16 Option Award | 2023-10-17 5:02 pm | N/A 2033-10-16 | Allogene Therapeutics Inc. | ALLO | Parker Geoffrey M. CHIEF FINANCIAL OFFICER | 1,740,000 | $0 | 1,740,000 (Direct) | View |
| 2023-06-07 Option Award | 2023-06-09 6:55 pm | N/A 2033-06-06 | Better Therapeutics Inc. | BTTX | Parker Geoffrey M. Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2023-05-17 Exercise | 2023-05-19 2:38 pm | N/A N/A | PERRIGO Co plc | PRGO | Parker Geoffrey M. Director | 7,778 | $32.86 | 37,084 (Direct) | View |
| 2023-05-17 Exercise | 2023-05-19 2:38 pm | N/A N/A | PERRIGO Co plc | PRGO | Parker Geoffrey M. Director | 7,778 | $0 | 37,084 (Direct) | View |
| 2023-05-17 Tax Withholding | 2023-05-19 2:38 pm | N/A N/A | PERRIGO Co plc | PRGO | Parker Geoffrey M. Director | 3,734 | $32.86 | 37,084 (Direct) | View |
| 2023-05-15 Option Award | 2023-05-17 3:40 pm | N/A N/A | PERRIGO Co plc | PRGO | Parker Geoffrey M. Director | 8,764 | $0 | 41,804 (Direct) | View |
| 2022-10-20 Disposition | 2022-10-24 7:08 pm | N/A N/A | ChemoCentryx Inc. | CCXI | Parker Geoffrey M. Director | 200,781 | $0 | 0 (Direct) | View |
| 2022-06-09 Option Award | 2022-06-10 4:42 pm | N/A 2032-06-08 | Better Therapeutics Inc. | BTTX | Parker Geoffrey M. Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2022-05-26 Option Award | 2022-05-31 9:35 pm | N/A N/A | ChemoCentryx Inc. | CCXI | Parker Geoffrey M. Director | 24,065 | $0 | 24,065 (Direct) | View |
| 2022-05-20 Exercise | 2022-05-24 8:13 pm | N/A N/A | ChemoCentryx Inc. | CCXI | Parker Geoffrey M. Director | 7,726 | $0 | 150,489 (Direct) | View |
| 2022-05-17 Exercise | 2022-05-19 1:52 pm | N/A N/A | PERRIGO Co plc | PRGO | Parker Geoffrey M. Director | 6,599 | $0 | 35,818 (Direct) | View |
| 2022-05-17 Exercise | 2022-05-19 1:52 pm | N/A N/A | PERRIGO Co plc | PRGO | Parker Geoffrey M. Director | 6,599 | $38.57 | 35,818 (Direct) | View |
| 2022-05-17 Option Award | 2022-05-19 1:52 pm | N/A N/A | PERRIGO Co plc | PRGO | Parker Geoffrey M. Director | 7,778 | $0 | 35,818 (Direct) | View |
| 2022-05-17 Tax Withholding | 2022-05-19 1:52 pm | N/A N/A | PERRIGO Co plc | PRGO | Parker Geoffrey M. Director | 3,168 | $38.57 | 35,818 (Direct) | View |
| 2022-05-02 Exercise | 2022-05-03 10:29 am | N/A 2022-06-22 | ChemoCentryx Inc. | CCXI | Parker Geoffrey M. Director | 12,500 | $0 | 142,763 (Direct) | View |
| 2022-05-02 Exercise | 2022-05-03 10:29 am | N/A N/A | ChemoCentryx Inc. | CCXI | Parker Geoffrey M. Director | 12,500 | $14.42 | 142,763 (Direct) | View |
| 2022-02-28 Option Award | 2022-03-02 4:49 pm | N/A 2032-02-27 | Tricida Inc. | TCDA | Parker Geoffrey M. COO, CFO and EVP | 256,000 | $0 | 256,000 (Direct) | View |
| 2021-12-31 Tax Withholding | 2022-01-04 4:18 pm | N/A N/A | Tricida Inc. | TCDA | Parker Geoffrey M. COO, CFO and EVP | 1,384 | $9.56 | 420,284 (Direct) | View |
| 2021-11-15 Option Award | 2021-11-17 4:29 pm | N/A N/A | Tricida Inc. | TCDA | Parker Geoffrey M. COO, CFO and EVP | 166,667 | $6 | 586,671 (Indirect) | View |
| 2021-11-15 Option Award | 2021-11-17 4:29 pm | N/A N/A | Tricida Inc. | TCDA | Parker Geoffrey M. COO, CFO and EVP | 166,667 | $0 | 586,671 (Indirect) | View |
| 2021-10-28 Option Award | 2021-11-01 8:57 pm | N/A 2031-10-27 | Better Therapeutics Inc. | BTTX | Parker Geoffrey M. Director | 61,633 | $0 | 61,633 (Direct) | View |
Ownership | 2021-11-01 8:30 pm | N/A N/A | Better Therapeutics Inc. | BTTX | Parker Geoffrey M. Director | 0 | $0 | 33,333 (Indirect) | View |
| 2021-05-21 Exercise | 2021-05-24 8:09 pm | N/A N/A | ChemoCentryx Inc. | CCXI | Parker Geoffrey M. Director | 4,660 | $0 | 142,493 (Direct) | View |
| 2021-05-20 Option Award | 2021-05-24 8:09 pm | N/A N/A | ChemoCentryx Inc. | CCXI | Parker Geoffrey M. Director | 12,230 | $0 | 142,493 (Direct) | View |
| 2021-03-10 Gift | 2021-05-24 8:09 pm | N/A N/A | ChemoCentryx Inc. | CCXI | Parker Geoffrey M. Director | 4,000 | $0 | 142,493 (Indirect) | View |
| 2021-05-17 Option Award | 2021-05-19 12:59 pm | N/A N/A | PERRIGO Co plc | PRGO | Parker Geoffrey M. Director | 6,599 | $0 | 26,208 (Direct) | View |
| 2021-05-07 Exercise | 2021-05-11 2:56 pm | N/A N/A | PERRIGO Co plc | PRGO | Parker Geoffrey M. Director | 5,804 | $42.96 | 19,609 (Direct) | View |
| 2021-05-07 Exercise | 2021-05-11 2:56 pm | N/A N/A | PERRIGO Co plc | PRGO | Parker Geoffrey M. Director | 5,804 | $0 | 19,609 (Direct) | View |
| 2021-05-07 Tax Withholding | 2021-05-11 2:56 pm | N/A N/A | PERRIGO Co plc | PRGO | Parker Geoffrey M. Director | 2,786 | $42.96 | 19,609 (Direct) | View |
Ownership | 2021-02-04 8:05 pm | N/A N/A | ChemoCentryx Inc. | CCXI | Parker Geoffrey M. Director | 0 | $0 | 161,513 (Indirect) | View |
| 2020-06-15 Ownership | 2021-02-04 8:05 pm | N/A N/A | ChemoCentryx Inc. | CCXI | Parker Geoffrey M. Director | 5,000 | $0 | 161,513 (Indirect) | View |
| 2021-01-17 Option Award | 2021-01-20 5:16 pm | N/A 2031-01-16 | Tricida Inc. | TCDA | Parker Geoffrey M. CFO and EVP | 216,000 | $0 | 216,000 (Direct) | View |
| 2020-09-10 Option Award | 2020-09-14 8:33 pm | N/A N/A | Tricida Inc. | TCDA | Parker Geoffrey M. Chief Fin. Officer and EVP | 4,000 | $0 | 235,837 (Direct) | View |
| 2020-05-23 Exercise | 2020-05-26 8:55 pm | N/A N/A | ChemoCentryx Inc. | CCXI | Parker Geoffrey M. Director | 7,724 | $0 | 174,061 (Direct) | View |
| 2020-05-21 Option Award | 2020-05-26 8:55 pm | 2021-05-21 2030-05-21 | ChemoCentryx Inc. | CCXI | Parker Geoffrey M. Director | 7,548 | $0 | 174,061 (Direct) | View |